Optiver Holding
RCUS icon

Optiver Holding’s Arcus Biosciences RCUS Stock Holding History

Optiver Holding’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8K Buy
838
+541
+182% +$13.4K ﹤0.01% 1414
2026
Q1 		$6.42K Buy
297
+86
+41% +$1.86K ﹤0.01% 1335
2025
Q4 		$5.03K Sell
211
-461
-69% -$9.4K ﹤0.01% 1370
2025
Q3 		$9.14K Buy
+672
New +$6.99K ﹤0.01% 1356

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Optiver Holding's RCUS Position: Q2 2026 in Review

Optiver Holding increased its Arcus Biosciences (RCUS) stake by 182% in Q2 2026, buying an estimated $13.4K and bringing the position to 838 shares worth $25.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1414.

Optiver Holding first reported a position in RCUS in Q3 2025 and has held it in 4 quarters since. 231 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Optiver Holding held 838 shares of Arcus Biosciences worth $25.8K as of Q2 2026.
  • Optiver Holding bought 541 Arcus Biosciences shares in Q2 2026, an estimated $13.4K.
  • Arcus Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q2 2026, its #1414 holding.
  • Optiver Holding first reported a position in Arcus Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 231 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Optiver Holding's 13F filing for Q2 2026, filed 12 Aug 2026.